Literature DB >> 21544592

Co-transplantation of fetal bone tissue facilitates the development and reconstitution in human B cells in humanized NOD/SCID/IL-2Rγnull (NSG) mice.

Miyoung Kim1, Bongkum Choi, So Yong Kim, Ji-Hyuk Yang, Cheong Rae Roh, Ki-Young Lee, Sung Joo Kim.   

Abstract

BACKGROUND: In terms of the function and reconstitution efficacy of human immune cells, co-transplantation of human fetal tissues, such as thymus and liver, with CD34(+) hematopoietic stem cells (HSCs) has potential advantages in the generation of humanized mice. OBJECTIVE AND METHODS: To examine the effects of bone tissues in the reconstitution of human immune cells, particularly in B cells, we generated a new humanized mice co-transplanted with human fetal thymus (hFT)/fetal bone (hFB) tissues and human fetal liver-derived CD34(+) cells.
RESULTS: Humanized mice exhibited effective reconstitution of human immune cells earlier compared to control humanized mice. In terms of quantity, the number of immune cells, such as human T, B, and monocyte/macrophages was significantly increased. Furthermore, significant increase of B cell progenitors and immature/naïve B cells could be detected in the bone marrow and spleen of humanized mice.
CONCLUSION: Our results demonstrate that co-transplantation of hFB tissue may facilitate the reconstitution of human B and T cells, and therefore the humanized model may be used to develop therapeutic human antibodies for clinical use.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544592     DOI: 10.1007/s10875-011-9538-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  35 in total

1.  Development of a human adaptive immune system in cord blood cell-transplanted mice.

Authors:  Elisabetta Traggiai; Laurie Chicha; Luca Mazzucchelli; Lucio Bronz; Jean-Claude Piffaretti; Antonio Lanzavecchia; Markus G Manz
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

2.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

3.  Mechanisms of tolerance to parental parathyroid tissue when combined with human allogeneic thymus transplantation.

Authors:  Ivan K Chinn; John A Olson; Michael A Skinner; Elizabeth A McCarthy; Stephanie E Gupton; Dong-Feng Chen; Francisco A Bonilla; Robert L Roberts; Maria G Kanariou; Blythe H Devlin; M Louise Markert
Journal:  J Allergy Clin Immunol       Date:  2010-09-15       Impact factor: 10.793

4.  Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice.

Authors:  Stefan Baenziger; Roxane Tussiwand; Erika Schlaepfer; Luca Mazzucchelli; Mathias Heikenwalder; Michael O Kurrer; Silvia Behnke; Joachim Frey; Annette Oxenius; Helen Joller; Adriano Aguzzi; Markus G Manz; Roberto F Speck
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-12       Impact factor: 11.205

5.  Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses.

Authors:  Satoru Watanabe; Kazuo Terashima; Shinrai Ohta; Shigeo Horibata; Misako Yajima; Yoko Shiozawa; M Zahidunnabi Dewan; Zhong Yu; Mamoru Ito; Tomohiro Morio; Norio Shimizu; Mitsuo Honda; Naoki Yamamoto
Journal:  Blood       Date:  2006-09-05       Impact factor: 22.113

6.  Dengue fever in humanized NOD/SCID mice.

Authors:  Dennis A Bente; Michael W Melkus; J Victor Garcia; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants.

Authors:  M Louise Markert; Blythe H Devlin; Marilyn J Alexieff; Jie Li; Elizabeth A McCarthy; Stephanie E Gupton; Ivan K Chinn; Laura P Hale; Thomas B Kepler; Min He; Marcella Sarzotti; Michael A Skinner; Henry E Rice; Jeffrey C Hoehner
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

8.  Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/gammac(null) (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells.

Authors:  Takuya Matsumura; Yoshie Kametani; Kiyoshi Ando; Yasuyuki Hirano; Ikumi Katano; Ryoji Ito; Masashi Shiina; Hideo Tsukamoto; Yuki Saito; Yutaka Tokuda; Shunichi Kato; Mamoru Ito; Kazuo Motoyoshi; Sonoko Habu
Journal:  Exp Hematol       Date:  2003-09       Impact factor: 3.084

9.  Immune-cell lineage commitment: translation from mice to humans.

Authors:  Kimberly J Payne; Gay M Crooks
Journal:  Immunity       Date:  2007-06       Impact factor: 31.745

10.  Humanized mice: are we there yet?

Authors:  Francesca Macchiarini; Markus G Manz; A Karolina Palucka; Leonard D Shultz
Journal:  J Exp Med       Date:  2005-11-21       Impact factor: 14.307

View more
  8 in total

Review 1.  Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap.

Authors:  J Jason Morton; Gregory Bird; Yosef Refaeli; Antonio Jimeno
Journal:  Cancer Res       Date:  2016-09-01       Impact factor: 12.701

2.  Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis.

Authors:  Melanie C Dispenza; Rebecca A Krier-Burris; Krishan D Chhiba; Bradley J Undem; Piper A Robida; Bruce S Bochner
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

3.  Human delta like 1-expressing human mesenchymal stromal cells promote human T cell development and antigen-specific response in humanized NOD/SCID/IL-2R[Formula: see text]null (NSG) mice.

Authors:  Do Hee Kwon; Jae Berm Park; Joo Sang Lee; Sung Joo Kim; Bongkum Choi; Ki-Young Lee
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

4.  An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rγnull mice allows HIV replication and development of anti-HIV immune responses.

Authors:  Maneesh Singh; Pratibha Singh; Gilles Gaudray; Lucia Musumeci; Caroline Thielen; Dolores Vaira; Claire Vandergeeten; Laurence Delacroix; Ellen Van Gulck; Guido Vanham; Laurence de Leval; Souad Rahmouni; Michel Moutschen
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

5.  Humanizing NOD/SCID/IL-2Rγnull (NSG) mice using busulfan and retro-orbital injection of umbilical cord blood-derived CD34(+) cells.

Authors:  Young Kyung Kang; Yunmi Ko; Aery Choi; Hyeong Jwa Choi; Jin-Hee Seo; Minyoung Lee; Jun Ah Lee
Journal:  Blood Res       Date:  2016-03-25

Review 6.  Application of Humanized Mice in Immunological Research.

Authors:  Wenwei Tu; Jian Zheng
Journal:  Methods Mol Biol       Date:  2016

7.  Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47phox-Deficient Chronic Granulomatous Disease.

Authors:  Andrea Schejtman; Winston Vetharoy; Uimook Choi; Christine Rivat; Narda Theobald; Giuseppa Piras; Diego Leon-Rico; Karen Buckland; Elena Armenteros-Monterroso; Sara Benedetti; Michael T Ashworth; Michael Rothe; Axel Schambach; Hubert Bobby Gaspar; Elizabeth M Kang; Harry L Malech; Adrian J Thrasher; Giorgia Santilli
Journal:  Hum Gene Ther       Date:  2021-05-06       Impact factor: 5.695

Review 8.  Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges.

Authors:  Sarah K Hakuno; Ellis Michiels; Eleonore B Kuhlemaijer; Ilse Rooman; Lukas J A C Hawinkels; Marije Slingerland
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.